Skip to content

Automatic Control of Total Intravenous Anesthesia (ACTIVA)

Automatic Control of Total Intravenous Anesthesia: Closed-loop Delivery of Propofol and Remifentanil Using Bispectral Index as Feedback Variable

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04432974
Acronym
ACTIVA
Enrollment
139
Registered
2020-06-16
Start date
2019-07-02
Completion date
2023-04-04
Last updated
2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia

Keywords

Closed-loop Anesthesia, PID Control, Medical Control Systems, Automated Drug Delivery, Propofol, Remifentanil, Bispectral index, BIS

Brief summary

This study concerns the clinical evaluation of a closed loop control system for the automatic administration of anesthetic drugs in TIVA (Total Intra Venous Anesthesia). The purpose of the experimentation is to demonstrate that the control system under study is reliable, safe, applicable and capable of inducing and maintaining an optimal anesthetic level.

Detailed description

This clinical study consists of the application of the ACTIVA control software for the infusion of intravenous drugs during general anesthesia according to the principle of closed-loop anesthesia. The objective of the experimentation is to evaluate the reliability, safety and applicability of the infusion system for anesthetic drugs controlled by the ACTIVA software and to carry out the clinical evaluation of the automatic control system during the induction and maintenance of general intravenous anesthesia. The benefits for enrolled patients could be linked to greater stability of anesthesia in the induction and maintenance phases. Constant closed-loop control of infusions and the level of hypnosis could also reduce the hemodynamic impact that general anesthesia has on the patient, by reducing the onset of hypotension episodes. Enrolled patients will undergo closed-loop anesthesia under the constant supervision of the investigator. The anesthetic drugs used are those recommended for general intravenous anesthesia: propofol and remifentanil. Identification and description of the medical device: The medical device object of the clinical investigation consists of the ACTIVA control software developed to control the infusion of anesthetic drugs during general intravenous anesthesia. ACTIVA software has been developed to optimize the infusion of anesthetic drugs according to a closed-loop system that allows the induction and maintenance of a constant and optimal level of anesthesia on the patient. ACTIVA control software is installed on a personal computer (PC). The level of anesthesia is measured according to the Bispectral Index (BIS) which measures the depth of hypnosis. Through the measurement of the BIS, the administration of anesthetic drugs is automatically regulated by the ACTIVA software and constantly supervised by the anesthesiologist through the graphic interface integrated in the software. The population for which the device is intended is made up of patients to undergo surgery for which general anesthesia is required, and intravenous anesthesia may be advantageous. During its operation, the ACTIVA software maintains the desired BIS level, selected by the anesthesiologist through the graphical user interface, communicating the appropriate infusion rate of the propofol and remifentanil anesthetic drugs to the syringe pumps. ACTIVA software communicates with the pumps and the BIS monitoring system with serial connections. These connections are native to the instrumentation used; therefore, no type of modification or manipulation has been made on the medical devices used. Closed-loop anesthesia: A closed-loop system can be defined as an automatic control system that bases its operation on the principle of feedback. Its key elements are a system to be controlled, a measuring device (sensor), a controller and an actuator. The sensor measures the controlled variable (system output), which is compared with the desired set-point. The difference between the latter and the output, defined as an error, is used to calculate the value of the control variable (system input). In the case of closed-loop anesthesia, the system to be controlled identifies with the patient, the actuator is represented by the syringe pump, the controlled variable corresponds to the BIS and the control variable is represented by the rate of infusion of the drugs. The controller used is a proportional-integral-derivative (PID) it relates the error signal and the control variable by means of three constants (Kp, Ti and Td) allowing a correct infusion of the drugs considering the present value of the error ( proportional action), the past values of the error (integral action) and the advance of the future values of the error (derivative action). These three constants, if properly calibrated, allow to obtain a controller with good performance and robustness. For the ACTIVA system the calibration of these constants was carried out by means of optimization methods performed in simulation. The anesthesiologist has at his disposal a PC with a graphical user interface through which he can control the start and end of the drug infusion and on which there are the commands through which it is possible to interact with the system. The graphical interface also reports indicators concerning the correct functioning of the control system. In case of malfunction of the ACTIVA software, the patient monitoring systems are never altered or damaged and the infusive pumps continue to operate in manual mode. Switching to manual control is always possible if the anesthesiologist considers it appropriate, even without the presence of system malfunctions.

Interventions

DEVICEAutomatic closed-loop anesthesia

Total intravenous anesthesia performed with the ACTIVA automatic control system

Sponsors

Università degli Studi di Brescia
CollaboratorOTHER
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients undergoing total intravenous general anesthesia for elective surgery

Exclusion criteria

* Patients under the age of 18 * Patients incapable of giving consent

Design outcomes

Primary

MeasureTime frameDescription
Depth of Hypnosis AdequacyDuring anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.The depth of hypnosis adequacy is assessed by evaluating, for each patient enrolled, the percentage of maintenance duration during which the Bispectral Index Scale (BIS) is kept within the recommended range from 40 to 60 (BIS \[40,60\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the BIS is kept below 40 (BIS\<40) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. The BIS ranges from 0 (absence of brain activity) to 100 (fully awake patient).

Secondary

MeasureTime frameDescription
Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreDuring anesthesia from the time instant when the automatic control is started to the point at which the automatic control is turned off at the conclusion of surgery, an average of 2 hours.Levels of satisfaction of the experimenter regarding three aspects of the ACTIVA system. The first aspect is the ease of use of the ACTIVA software and its infusion system. The second aspect is the behavior of the ACTIVA system during the induction phase of anesthesia. The third aspect is the behavior of the ACTIVA system during the maintenance phase of anesthesia. For each aspect, the level of satisfaction is expressed by the experimenter by assigning a score on a scale ranging from 0 (extremely unsatisfied) to 10 (extremely satisfied). Thus, higher values represent a better outcome. Note that the scoring scale employed is the same for each of the three aspects. The results are reported in a table divided in three rows, one for each aspect evaluated. Each row is divided in eleven categories representing the scores from 0 to 10. For each category it is indicated the number of patients for which the experimenter expressed that specific score.
Effect of Drugs Delivery on Heart RateDuring anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.The effect of drugs delivery on heart rate is assessed by evaluating, for each patient enrolled, the percentage of the anesthesia maintenance duration in which the heart rate (HR) is kept inside the range from 50 to 100 beats per minute (HR \[50,100\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the HR is kept below 50 (HR\<50) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.
Effect of Drugs Delivery on Mean Arterial Pressure (MAP)During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.The effect of drugs delivery on mean arterial pressure (MAP) is assessed by evaluating, for each patient enrolled, the anesthesia maintenance duration in which the non-invasively measured MAP is kept inside the range from 65 to 110 mmHg (MAP \[65,110\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the MAP is kept below 65 (MAP\<65) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. MAP is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure).
Postoperative Heart Rate StabilityEnd of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.The postoperative heart rate is assessed by measuring the heart rate in beats per minute (bpm).
Number of Participants for Which the System Showed DysfunctionsDuring anesthesia from the time instant when the automatic control is started to the point at which the automatic control is turned off at the conclusion of surgery, an average of 2 hours.Number of participants for which the ACTIVA system showed dysfunctions. The results are presented in a table where each row indicates the type of dysfunction and the number of participants for which that particular type of dysfunction occurred.
Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreEnd of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.The postoperative sedation is assessed by means of a Sedation Score scale. It is a 3 point scale from 0 (fully awake) to 3 (fully sedated)
Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreEnd of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.Postoperative Nausea and Vomiting is assessed by means of the Bellville PONV scale. It is a 3 point scale from 0 (no nausea & vomiting) to 3 (vomiting present)
Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreEnd of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.The postoperative analgesia is assessed using a 10-point numeric rating scale (NRS). It is a 10 point scale from 0 (no pain) to 10 (maximum pain).
Postoperative Mean Arterial Pressure (MAP) StabilityEnd of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.The postoperative mean arterial pressure (MAP) stability is assessed by non-invasively measuring the MAP with an electronic sphygmomanometer trough an inflatable cuff. Mean arterial pressure (MAP) is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure).

Countries

Italy

Participant flow

Recruitment details

The recruited patients were patients scheduled for elective plastic surgery for whom general anesthesia performed in TIVA was deemed appropriate. The recruitments took place at the Spedali Civili di Brescia hospital, in the plastic surgery operating room. The first participant was enrolled on July 2, 2019 and the last participant was enrolled on April 4, 2023.

Pre-assignment details

Patients were approached and informed of the possibility to participate in the study during the preoperative anesthesia visit, which takes place two weeks before the scheduled surgical procedure. If the patient wishes to participate in the study, the informed consent is obtained on the day of surgery, at the patient's arrival in the preoperative holding area.

Participants by arm

ArmCount
ACTIVA
Participants received total intravenous anesthesia performed with the ACTIVA automatic control system.
139
Total139

Baseline characteristics

CharacteristicACTIVA
Age, Continuous57 years
ASA status
ASA 1
12 Participants
ASA status
ASA 2
96 Participants
ASA status
ASA 3
31 Participants
Heart rate71 beats per minute
Height165 cm
Mean arterial pressure100 mmHg
PONV risk
0
8 Participants
PONV risk
1
34 Participants
PONV risk
2
39 Participants
PONV risk
3
45 Participants
PONV risk
4
13 Participants
Race and Ethnicity Not Collected— Participants
Region of Enrollment
Italy
139 Participants
Sex: Female, Male
Female
98 Participants
Sex: Female, Male
Male
41 Participants
Type of surgery
Brachioplasty
1 Participants
Type of surgery
Electrochemotherapy
7 Participants
Type of surgery
Eyelid surgery
2 Participants
Type of surgery
Lipofilling
5 Participants
Type of surgery
Mastectomy
34 Participants
Type of surgery
Mastoplasty
28 Participants
Type of surgery
Rhinoplasty
1 Participants
Type of surgery
Skin cancer exeresis
54 Participants
Type of surgery
Surgical treatment of wounds
7 Participants
Weight70 kg

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 139
other
Total, other adverse events
0 / 139
serious
Total, serious adverse events
0 / 139

Outcome results

Primary

Depth of Hypnosis Adequacy

The depth of hypnosis adequacy is assessed by evaluating, for each patient enrolled, the percentage of maintenance duration during which the Bispectral Index Scale (BIS) is kept within the recommended range from 40 to 60 (BIS \[40,60\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the BIS is kept below 40 (BIS\<40) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. The BIS ranges from 0 (absence of brain activity) to 100 (fully awake patient).

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureGroupValue (MEDIAN)
ACTIVADepth of Hypnosis AdequacyBIS [40,60]79.4 percentage of maintenance duration
ACTIVADepth of Hypnosis AdequacyBIS<4016.2 percentage of maintenance duration
Secondary

Effect of Drugs Delivery on Heart Rate

The effect of drugs delivery on heart rate is assessed by evaluating, for each patient enrolled, the percentage of the anesthesia maintenance duration in which the heart rate (HR) is kept inside the range from 50 to 100 beats per minute (HR \[50,100\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the HR is kept below 50 (HR\<50) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureGroupValue (MEDIAN)
ACTIVAEffect of Drugs Delivery on Heart RateHR<500.3 percentage of maintanance duration
ACTIVAEffect of Drugs Delivery on Heart RateHR [50,100]99.7 percentage of maintanance duration
Secondary

Effect of Drugs Delivery on Mean Arterial Pressure (MAP)

The effect of drugs delivery on mean arterial pressure (MAP) is assessed by evaluating, for each patient enrolled, the anesthesia maintenance duration in which the non-invasively measured MAP is kept inside the range from 65 to 110 mmHg (MAP \[65,110\]). The outcome measure is defined as the median of these percentages calculated over all the patients enrolled in the study. The median of the percentages, calculated over all the patients enrolled in the study, of the anesthesia maintenance duration in which the MAP is kept below 65 (MAP\<65) is also specified. Maintenance duration is the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds. MAP is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure).

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureGroupValue (MEDIAN)
ACTIVAEffect of Drugs Delivery on Mean Arterial Pressure (MAP)MAP [65,110]79.0 percentage of maintenance duration
ACTIVAEffect of Drugs Delivery on Mean Arterial Pressure (MAP)MAP<6515.7 percentage of maintenance duration
Secondary

Levels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific Score

Levels of satisfaction of the experimenter regarding three aspects of the ACTIVA system. The first aspect is the ease of use of the ACTIVA software and its infusion system. The second aspect is the behavior of the ACTIVA system during the induction phase of anesthesia. The third aspect is the behavior of the ACTIVA system during the maintenance phase of anesthesia. For each aspect, the level of satisfaction is expressed by the experimenter by assigning a score on a scale ranging from 0 (extremely unsatisfied) to 10 (extremely satisfied). Thus, higher values represent a better outcome. Note that the scoring scale employed is the same for each of the three aspects. The results are reported in a table divided in three rows, one for each aspect evaluated. Each row is divided in eleven categories representing the scores from 0 to 10. For each category it is indicated the number of patients for which the experimenter expressed that specific score.

Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the automatic control is turned off at the conclusion of surgery, an average of 2 hours.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction00 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction10 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction20 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction40 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction50 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction723 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction856 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction942 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction00 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction10 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction20 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction67 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction714 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction835 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction953 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction1030 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance00 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance10 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance20 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance30 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance40 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance50 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance610 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance948 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance1033 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction30 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction66 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreGeneral level of satisfaction1012 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction30 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction40 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia induction50 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance716 Participants
ACTIVALevels of Satisfaction of the Experimenter Expressed as Number of Participants Who Have Received a Specific ScoreLevel of satisfaction regarding anesthesia maintenance832 Participants
Secondary

Number of Participants for Which the System Showed Dysfunctions

Number of participants for which the ACTIVA system showed dysfunctions. The results are presented in a table where each row indicates the type of dysfunction and the number of participants for which that particular type of dysfunction occurred.

Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the automatic control is turned off at the conclusion of surgery, an average of 2 hours.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
ACTIVANumber of Participants for Which the System Showed DysfunctionsVenous access occlusion8 Participants
ACTIVANumber of Participants for Which the System Showed DysfunctionsInfusion pumps failure8 Participants
ACTIVANumber of Participants for Which the System Showed DysfunctionsNo system dysfunctions123 Participants
Secondary

Postoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score

The postoperative analgesia is assessed using a 10-point numeric rating scale (NRS). It is a 10 point scale from 0 (no pain) to 10 (maximum pain).

Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission092 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission14 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission27 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission36 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission413 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission56 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission63 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission75 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission82 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission90 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission101 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge074 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge16 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge216 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge318 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge47 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge56 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge65 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge76 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge81 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge90 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery071 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery112 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery217 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery54 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery63 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery72 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery80 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery90 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery100 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery088 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery118 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery212 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery39 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery47 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery54 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery60 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery70 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery81 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery90 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery100 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge100 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery318 Participants
ACTIVAPostoperative Analgesia Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery412 Participants
Secondary

Postoperative Heart Rate Stability

The postoperative heart rate is assessed by measuring the heart rate in beats per minute (bpm).

Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.

ArmMeasureGroupValue (MEDIAN)
ACTIVAPostoperative Heart Rate StabilityOperating room discharge72 beats per minute
ACTIVAPostoperative Heart Rate StabilityRecovery room admission74 beats per minute
ACTIVAPostoperative Heart Rate StabilityRecovery room discharge74 beats per minute
ACTIVAPostoperative Heart Rate Stability6 hours after surgery74 beats per minute
ACTIVAPostoperative Heart Rate Stability24 hours after surgery72 beats per minute
Secondary

Postoperative Mean Arterial Pressure (MAP) Stability

The postoperative mean arterial pressure (MAP) stability is assessed by non-invasively measuring the MAP with an electronic sphygmomanometer trough an inflatable cuff. Mean arterial pressure (MAP) is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure).

Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.

ArmMeasureGroupValue (MEDIAN)
ACTIVAPostoperative Mean Arterial Pressure (MAP) StabilityOperating room discharge82 mmHg
ACTIVAPostoperative Mean Arterial Pressure (MAP) StabilityRecovery room admission83 mmHg
ACTIVAPostoperative Mean Arterial Pressure (MAP) StabilityRecovery room discharge85 mmHg
ACTIVAPostoperative Mean Arterial Pressure (MAP) Stability6 hours after surgery90 mmHg
ACTIVAPostoperative Mean Arterial Pressure (MAP) Stability24 hours after surgery88 mmHg
Secondary

Postoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score

Postoperative Nausea and Vomiting is assessed by means of the Bellville PONV scale. It is a 3 point scale from 0 (no nausea & vomiting) to 3 (vomiting present)

Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission0136 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission13 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission20 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission30 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge0133 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge14 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge21 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge31 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery0135 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery14 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery20 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery30 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery0136 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery12 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery20 Participants
ACTIVAPostoperative Nausea and Vomiting (PONV) Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery31 Participants
Secondary

Postoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score

The postoperative sedation is assessed by means of a Sedation Score scale. It is a 3 point scale from 0 (fully awake) to 3 (fully sedated)

Time frame: End of anesthesia (operating room discharge, recovery room admission, recovery room discharge), 6 hours after surgery, 24 hours after surgery.

ArmMeasureGroupCategoryValue (COUNT_OF_PARTICIPANTS)
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission097 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission140 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission22 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room admission30 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge124 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge20 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge30 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery0135 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery14 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery20 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score6 hours after surgery30 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery0139 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery10 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery20 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific Score24 hours after surgery30 Participants
ACTIVAPostoperative Sedation Expressed as Number of Participants Who Have Received a Specific ScoreRecovery room discharge0115 Participants
Post Hoc

Extubation Time

The extubation time is the time interval that elapses from the time instant when the automatic control is stopped to when the patient is extubated. It is an indicator of the awakening time.

Time frame: During anesthesia from the time instant when the automatic control is stopped to when the patient is extubated, up to 11 minutes.

ArmMeasureValue (MEDIAN)
ACTIVAExtubation Time496 seconds
Post Hoc

Global Score (GS)

The Global Score (GS) is a performance index that characterize the overall control performance. It is calculated as (MDAPE+WOBBLE)/BIS \[40,60\]. For each patient (i) and for each Bispectral Index Scale (BIS) sample (j): PEij=((BISij BIS\_Target)/BIS\_Target)\*100, with BIS\_Target=50. MDAPEi=median{\|PEij\|}. WOBBLEi=median{\|PEij-MDPEi\|}. BIS \[40,60\] is the percentage of the anesthesia maintenance duration in which the BIS is kept between 40 and 60. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction, defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds, to the point at which the automatic control is turned off at the conclusion of surgery. The GS ranges from zero to infinity. The lower the GS, the better the control performance. Specifically, a GS value of zero would correspond to the case where the BIS is always maintained at its target value.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (MEDIAN)
ACTIVAGlobal Score (GS)26.3 Dimensionless
Post Hoc

Induction Time

The induction time is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds, an average of 110 seconds.

ArmMeasureValue (MEDIAN)
ACTIVAInduction Time103 seconds
Post Hoc

Lowest Bispectral Index (BIS) Induction

The lowest Bispectral Index (BIS) is the lowest BIS value observed within the 60 seconds following the induction time. The BIS quantifies the cerebral activity and ranges from 99 (corresponding to a fully awake and aware patient) to 0 (corresponding to the absence of brain activity. For general anesthesia it is recommended to keep the BIS inside the range 40-60. Values above 60 represent a too light anesthesia while values below 40 represents a too deep anesthesia.

Time frame: During anesthesia from the time instant when the automatic control is started to 60 seconds following the induction time, an average of 170 seconds.

ArmMeasureValue (MEDIAN)
ACTIVALowest Bispectral Index (BIS) Induction42 units on a scale (BIS)
Post Hoc

Lowest Heart Rate Induction

The lowest heart rate is the lowest heart rate value observed within the 5 minutes following the induction time.

Time frame: During anesthesia from the time instant when the automatic control is started to the 5 minutes following the induction time, an average of 410 seconds.

ArmMeasureValue (MEDIAN)
ACTIVALowest Heart Rate Induction54 beats per minute
Post Hoc

Lowest Mean Arterial Pressure (MAP) Induction

The lowest mean arterial pressure (MAP) is the lowest value of the MAP observed within the 5 minutes following the induction time. It is assessed by non-invasively measuring the MAP with an electronic sphygmomanometer embedded in a multiparametric patient monitor through an inflatable cuff. Mean arterial pressure (MAP) is defined as diastolic pressure + 1/3(systolic pressure - diastolic pressure).

Time frame: During anesthesia from the time instant when the automatic control is started to the 5 minutes following the induction time, an average of 410 seconds.

ArmMeasureValue (MEDIAN)
ACTIVALowest Mean Arterial Pressure (MAP) Induction69 mmHg
Post Hoc

MDAPE

The MDAPE is the median absolute performance error calculated during the maintenance phase. The performance error (PE) is calculated for each patient (i) and for each BIS sample (j) according to the formula: PEij=((BISij-BIS\_Target)/BIS\_Target)\*100, where BIS\_Target is set equal to 50. The MDAPE is a measure of inaccuracy. The MDAPE is calculated according to the formula: MDAPEi=median{\|PEij\|}. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (MEDIAN)
ACTIVAMDAPE12 percentage of target BIS value
Post Hoc

MDPE

The MDPE is the median performance error calculated during the maintenance phase. The performance error (PE) is calculated for each patient (i) and for each BIS sample (j) according to the formula: PEij=((BISij-BIS\_Target)/BIS\_Target)\*100, where BIS\_Target is set equal to 50. The MDPE is a measure of bias and describes whether the measured BIS values are systematically distributed either above or below the BIS target. The MDPE is calculated according to the formula: MDPEi=median{PEij}. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (MEDIAN)
ACTIVAMDPE-10 percentage of target BIS value
Post Hoc

Median Maintenance Propofol Effect-Site Concentration

It is the median propofol effect-site concentration achieved by the ACTIVA system during the maintenance phase of anesthesia. It is estimated according to the Schnider model. The outcome measure is defined as the median of the propofol effect-site concentrations achieved by the ACTIVA system during the maintenance phase of anesthesia calculated over all the patients enrolled in the study. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (MEDIAN)
ACTIVAMedian Maintenance Propofol Effect-Site Concentration2.72 ug/ml
Post Hoc

Median Maintenance Propofol Infusion Rate

It is the median value of the propofol infusion rate administered by the ACTIVA system during the maintenance phase of anesthesia. The outcome measure is defined as the median of the propofol infusion rates administered by the ACTIVA system during the maintenance phase of anesthesia calculated over all the patients enrolled in the study. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (MEDIAN)
ACTIVAMedian Maintenance Propofol Infusion Rate6.19 mg/kg/h
Post Hoc

Median Maintenance Remifentanil Effect-Site Concentration

It is the median remifentanil effect-site concentration achieved by the ACTIVA system during the maintenance phase of anesthesia. It is estimated according to the Minto model. The outcome measure is defined as the median of the remifentanil effect-site concentrations achieved by the ACTIVA system during the maintenance phase of anesthesia calculated over all the patients enrolled in the study. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (MEDIAN)
ACTIVAMedian Maintenance Remifentanil Effect-Site Concentration5.02 ng/ml
Post Hoc

Median Maintenance Remifentanil Infusion Rate

It is the median value of the remifentanil infusion rate administered by the ACTIVA system during the maintenance phase of anesthesia. The outcome measure is defined as the median of the remifentanil infusion rates administered by the ACTIVA system during the maintenance phase of anesthesia calculated over all the patients enrolled in the study. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (MEDIAN)
ACTIVAMedian Maintenance Remifentanil Infusion Rate0.16 ug/kg/min
Post Hoc

Number of Participants That Received Hemodynamic Interventions

Number of Participants that showed cases of hypotension treated with ephedrine or etilefrine before and after the beginning of the surgical stimulation (incision).

Time frame: During anesthesia from the time instant when the automatic control is started to incision for the cases before incision. During anesthesia from incision to the time instant when the automatic control is stopped for the cases after incision.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
ACTIVANumber of Participants That Received Hemodynamic InterventionsBefore incision26 Participants
ACTIVANumber of Participants That Received Hemodynamic InterventionsAfter incision71 Participants
Post Hoc

Number of Participants With Burst-Suppression Episode During Anesthesia Maintenance

Number of Participants that showed the occurrence of a burst-suppression episode during the maintenance phase. A burst-suppression episode is defined as a value of burst-suppression ratio (BSR) above 10% for at least 60 seconds. The maintenance phase here is defined as the period of time that goes from the 5 minutes after the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ACTIVANumber of Participants With Burst-Suppression Episode During Anesthesia Maintenance25 Participants
Post Hoc

Number of Participants With Burst-Suppression Episode Following Anesthesia Induction

Number of Participants that showed the occurrence of a burst-suppression episode within the 5 minutes following the induction time. A burst-suppression episode is defined as a value of burst-suppression ratio (BSR) above 10% for at least 60 seconds.

Time frame: During anesthesia from the time instant when the automatic control is started to the 5 minutes following the induction time, an average of 410 seconds.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
ACTIVANumber of Participants With Burst-Suppression Episode Following Anesthesia Induction6 Participants
Post Hoc

Propofol Induction Dose

Propofol dose administered by the system throughout the induction time.

Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds, an average of 170 seconds.

ArmMeasureValue (MEDIAN)
ACTIVAPropofol Induction Dose1.90 mg/kg
Post Hoc

Remifentanil Induction Dose

Remifentanil dose administered by the system throughout the induction time.

Time frame: During anesthesia from the time instant when the automatic control is started to the point at which the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds, an average of 170 seconds.

ArmMeasureValue (MEDIAN)
ACTIVARemifentanil Induction Dose2.16 ug/kg
Post Hoc

WOBBLE

The WOBBLE is an index of time-related changes in the performance and measures the intra-patient variability in performance errors. It is calculated during the maintenance phase. The performance error (PE) is calculated for each patient (i) and for each BIS sample (j) according to the formula: PEij=((BISij BIS\_Target)/BIS\_Target)\*100, where BIS\_Target is set equal to 50. The WOBBLE is calculated according to the formula: WOBBLEi=median{\|PEij-MDPEi\|}. The maintenance phase is defined as the period of time that goes from the end of anesthesia induction to the point at which the automatic control is turned off at the conclusion of surgery. The end of anesthesia induction is defined as the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds.

Time frame: During anesthesia from the time instant when the BIS drops below 60 for the first time and remains there for the subsequent 30 seconds to the point at which the automatic control is turned off (maintenance duration), an average of 2 hours.

ArmMeasureValue (MEDIAN)
ACTIVAWOBBLE8 percentage of target BIS value

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026